Please wait a minute...
文章检索
预防医学  2024, Vol. 36 Issue (1): 44-46    DOI: 10.19485/j.cnki.issn2096-5087.2024.01.011
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
呼吸道感染肠道病毒D68型病例特征分析
蒋卓婧1, 黄泽民1, 王吉玲2, 陈金堃2
1.绍兴市疾病预防控制中心微生物检验科,浙江 绍兴 312000;
2.绍兴市疾病预防控制中心,浙江 绍兴 312000
Characteristics of cases with enterovirus-D68 infectionsin the respiratory tract
JIANG Zhuojing1, HUANG Zemin1, WANG Jiling2, CHEN Jinkun2
1. Department of Microbiological Inspection, Shaoxing Center for Disease Control and Prevention, Shaoxing, Zhejiang 312071, China;
2. Shaoxing Center for Disease Control and Prevention, Shaoxing, Zhejiang 312071, China
全文: PDF(874 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解浙江省绍兴市10例呼吸道感染肠道病毒D68(EV-D68)型病例特征,为制定EV-D68感染防制策略提供依据。方法 收集2021—2022年绍兴市哨点医院就诊的急性呼吸道感染病例的基本情况和临床标本,采用实时荧光PCR和肠道病毒VP1区测序法检测EV-D68,描述性分析EV-D68阳性病例的流行病学和病原学特征。结果 2021—2022年共检测急性呼吸道感染病例3 009例,检出EV-D68阳性10例,阳性率为0.33%。其中,男性6例,女性4例;<18岁5例,18~60岁2例,>60岁3例;夏秋季高发,5—7月和9—10月各检出5例。临床症状以发热(10例)、咽痛(9例)和咳嗽(8例)为主;10例病例均恢复良好,无死亡报告。10份EV-D68阳性标本经序列比对均属于D3亚型。结论 绍兴市EV-D68引起的呼吸道感染主要感染18岁以下儿童青少年,夏秋季高发,D3亚型为主要流行型别。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
蒋卓婧
黄泽民
王吉玲
陈金堃
关键词 肠道病毒D68型呼吸道感染基因型病原学监测    
AbstractObjective To investigate the clinical and molecular epidemiological characteristics of 10 patients with enterovirus (EV)-D68 infections in the respiratory tract in Shaoxing City, Zhejiang Province, so as to provide insights into formulation of control interventions for EV-D68 infections. Methods Clinical specimens were sampled from patients with acute respiratory tract infections (ARTIs) admitted to sentinel hospitals in Shaoxing City from 2021 to 2022, and EV-D68 was detected using real-time fluorescent PCR assay and sequencing of the VP1 region of enterovirus. The epidemiological and etiological characteristics of EV-D68 infected cases were descriptively analyzed. Results A total of 3 009 specimens were sampled from patients with ARTIs from 2021 to 2022, and the detection of EV-D68 was 0.33%. Of all EV-D68-infected patients, there were 6 men and 4 women, and 5 cases under 18 years of age, 2 cases at ages of 18 to 60 years and 3 cases at ages of over 60 years. EV-D68 infection predominantly occurred in summer (5 cases detected between May and July) and autumn (5 cases detected between September and October). The main clinical symptoms included fever (10 cases), sore throat (9 cases) and cough (8 cases), and all 10 cases recovered well, with no deaths reported. Sequencing identified D3 subtype in all 10 specimens positive for EV-D68. Conclusions The ARTIs caused by EV-D68 occurred predominantly among children under 18 years of age in Shaoxing City, and was highly prevalent in summer and autumn. D3 was the predominant enterovirus subtype.
Key wordsenterovirus-D68    respiratory tract infection    genotype    etiological surveillance
收稿日期: 2023-08-11      修回日期: 2023-10-24      出版日期: 2024-01-10
中图分类号:  R373.2  
  R56  
基金资助:绍兴市级医卫类科技计划项目(2020A13056)
作者简介: 蒋卓婧,硕士,副主任技师,主要从事病原微生物分子检测工作
通信作者: 陈金堃,E-mail:453772128@qq.com   
引用本文:   
蒋卓婧, 黄泽民, 王吉玲, 陈金堃. 呼吸道感染肠道病毒D68型病例特征分析[J]. 预防医学, 2024, 36(1): 44-46.
JIANG Zhuojing, HUANG Zemin, WANG Jiling, CHEN Jinkun. Characteristics of cases with enterovirus-D68 infectionsin the respiratory tract. Preventive Medicine, 2024, 36(1): 44-46.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2024.01.011      或      http://www.zjyfyxzz.com/CN/Y2024/V36/I1/44
[1] GONZALEZ-SANZ R,TARAVILO I,REINA J,et al.Enterovirus D68-associated respiratory and neurological illness in Spain,2014-2018[J].Emerg Microbes Infect,2019,8(1):1438-1444.
[2] FUNAKOSHI Y,ITO K,MORINO S,et al.Enterovirus D68 respiratory infection in a children's hospital in Japan in 2015[J].Pediatr Int,2019,61(8):768-776.
[3] DREWS S J,SIMMONDS K,USMAN H R,et al.Characterization of enterovirus activity,including that of enterovirus D68,in pediatric patients in Alberta,Canada,in 2014[J].J Clin Microbiol,2015,53(3):1042-1045.
[4] MESSACA K,ABZUG M J,DOMINGUEZ S R.2014 outbreak of enterovirus D68 in North America[J].J Med Virol,2016,88(5):739-745.
[5] MESSACAR K,ASTURIAS E J,HIXON A M,et al.Enterovirus D68 and acute faccid myelitis-evaluating the evidence for causality[J].Lancet Infect Dis,2018,18(8):239-247.
[6] XIANG Z C,GONZALEZ R,WANG Z,et al.Coxsackievirus A21,enterovirus 68,and acute respiratory tract infection,China[J].Emerg Infect Dis,2012,18(5):821-824.
[7] ITAGAKI T,AOKI Y,MATOBA Y,et al.Clinical characteristics of children infected with enterovirus D68 in an outpatient clinic and the association with bronchial asthma[J].Infect Dis(Lond),2018,50(4):303-312.
[8] SCHUSTER J E,MILER J O,SELVARANGAN R,et al.Severe enterovirus 68 respiratory illness in children requiring intensive care management[J].J Clin Virol,2015,70:77-82.
[9] SOOKSAWASD NA AYUDHYA S,LAKSONO B M,VAN RIEL D.The pathogenesis and virulence of enterovirus-D68 infection[J].Virulence,2021,12(1):2060-2072.
[10] GRENINGER A L,NACCACHE S N,MESSACAR K,et al.A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA(2012-14):a retrospective cohort study[J].Lancet Infect Dis,2015,15:671-682.
[11] 庞孟涛,李傅冬,林君芬,等.2016—2019年浙江省手足口病流行特征[J].预防医学,2022,34(3):307-310.
[12] ZHANG T G,LI A H,CHEN M,et al.Respiratory infections associated with enterovirus D68 from 2011 to 2015 in Beijing,China[J].J Med Virol,2016,88(9):1529-1534.
[13] ABEDI G R,WATSON J T,NIX W A,et al.Enterovirus and parechovirus surveillance-United States,2014-2016[J].MMWR,2018,67(18):515-518.
[14] 李爱华,龚成,李茂中,等.2018—2019年北京市呼吸道感染病例中肠道病毒D68型临床和流行特征研究[J].疾病监测,2022,37(6):782-788.
[1] 刘丽迎, 康文娟, 董勤, 张晓刚, 阎亚琼. 53例苯丙酮尿症新生儿体格、智力和基因特征[J]. 预防医学, 2022, 34(9): 955-958.
[2] 杨茹莱, 沈亚平, 陈迟, 周莹, 徐艳华, 舒强. 2009—2021年浙江省新生儿遗传代谢病基因型分析[J]. 预防医学, 2022, 34(8): 760-764.
[3] 蒋卓婧, 葛小萍, 陈金堃, 王吉玲. 绍兴市手足口病病毒型别检测结果分析[J]. 预防医学, 2022, 34(5): 507-510.
[4] 任帆, 施妍尔, 嵇龙飞, 蔡云祥. 湖州市儿童急性下呼吸道感染病原体流行特征[J]. 预防医学, 2021, 33(6): 595-598.
[5] 陈晶, 刘思宇, 周灵玲. 丽水市儿童呼吸道感染常见病原体分析[J]. 预防医学, 2021, 33(5): 529-531.
[6] 翁正军, 陈波, 朱婧, 陈莫娇. 义乌市3起学校诺如病毒急性胃肠炎疫情的病原分子流行病学特征[J]. 预防医学, 2021, 33(3): 289-291.
[7] 叶静芬, 方晴, 胡耀仁, 许小敏, 车洋. 北京基因型耐多药结核分枝杆菌二线抗结核药物耐药基因突变特征分析[J]. 预防医学, 2021, 33(10): 983-987.
[8] 吴黎黎, 张素梅, 邵璇璇, 章宝芝, 赵寅生. 安徽省上消化系统疾病患者CYP2C19基因多态性研究[J]. 预防医学, 2021, 33(1): 31-34.
[9] 余昭, 孙琬琬, 刘社兰, 程伟, 潘金仁. 呼吸道传染病监测体系运行状况分析[J]. 预防医学, 2021, 33(1): 101-103.
[10] 刘卫光, 赵桂让, 黄道靖, 张智博, 孔振. 15岁以下严重急性呼吸道感染病例流感病毒检测结果分析[J]. 预防医学, 2020, 32(5): 516-518.
[11] 方芳, 赵丽丽, 徐庆嵩, 宋冰. 呼吸科住院病例医院感染病原菌分布及耐药性分析[J]. 预防医学, 2020, 32(4): 369-372.
[12] 阮尉月清, 刘家法, 张米, 李健健, 杨壁珲, 邓雪媚, 董兴齐. 云南省男男性行为人群HIV/AIDS病例抗病毒治疗失败基因型耐药分析[J]. 预防医学, 2020, 32(10): 987-991.
[13] 林永兴, 李娜. 中国老年人接种23价肺炎球菌多糖疫苗效果的Meta分析[J]. 预防医学, 2020, 32(10): 1022-1025.
[14] 邢洁, 朱笕青, 于爱军, 郑爱文. 浙江省高危HPV基因型分布热力图分析[J]. 预防医学, 2019, 31(8): 851-853.
[15] 李欢欢, 程伟, 刘社兰(综述), 陈恩富(审校). 呼吸道合胞病毒监测体系现状及展望[J]. 预防医学, 2019, 31(4): 359-362.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed